New Educational Childhood Asthma Campaign Launched by the American Lung … – Lung Disease News


Lung Disease News

New Educational Childhood Asthma Campaign Launched by the American Lung
Lung Disease News
childhood asthma The American Lung Association has partnered with WellPoint for the development of an informative learning series, called the Pediatric Learning Collaborative on Childhood Asthma program, to support children suffering from asthma, a

View full post on asthma – Google News

American Lung Association and WellPoint Collaborate to Help Educate About … – Business Wire (press release)

American Lung Association and WellPoint Collaborate to Help Educate About
Business Wire (press release)
According to the Centers for Disease Control and Prevention, asthma is a common, potentially life threatening condition, affecting more than seven million children in the U.S. It is a prevalent issue in our nation's schools. In a typical classroom of

and more »

View full post on asthma – Google News

American Lung Association and WellPoint Collaborate to Help Educate About … – MarketWatch

American Lung Association and WellPoint Collaborate to Help Educate About
MarketWatch
According to the Centers for Disease Control and Prevention, asthma is a common, potentially life threatening condition, affecting more than seven million children in the U.S. It is a prevalent issue in our nation's schools. In a typical classroom of

View full post on asthma – Google News

Allergy & Asthma Network Partners with American College of Allergy, Asthma … – SYS-CON Media (press release)

Allergy & Asthma Network Partners with American College of Allergy, Asthma
SYS-CON Media (press release)
ATLANTA, Oct. 27, 2014 /PRNewswire-USNewswire/ — Allergy & Asthma Network, the leading national nonprofit patient education organization dedicated to ending needless death and suffering due to asthma, allergies and related conditions, and the …

and more »

View full post on asthma – Google News

Mepolizumab May Substantially Reduce Asthma Exacerbations – JAMA: The Journal of the American Medical Association

Mepolizumab May Substantially Reduce Asthma Exacerbations
JAMA: The Journal of the American Medical Association
Mepolizumab, a humanized monoclonal antibody against interleukin-5, significantly reduced asthma exacerbations and improved quality of life among patients treated with inhaled glucocorticoids, according to a randomized, placebo-controlled trial with

and more »

View full post on asthma – Google News